Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Enanta Pharmaceuticals
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Data
Enanta Pharmaceuticals Announces Positive Topline Results in Healthy Adults Infected with Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals
PR-M06-19-NI-028
Jun 19, 2019
